Scientists test a ‘bispecific’ antibody that helps T cells zero in on treatment-resistant cancers

Although immunotherapy has achieved increasing prominence in the panoply of innovative cancer treatments, it remains an imperfect tool—too many tumors simply do not respond.

Read the full article here

Related Articles